• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型广谱青霉素Bay k 4999的药代动力学

Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.

作者信息

Wise R, Cadge B, Gillett A P, Bhamjee A, Livingston R, Welling P G, Thornhill D P

出版信息

Antimicrob Agents Chemother. 1979 May;15(5):670-3. doi: 10.1128/AAC.15.5.670.

DOI:10.1128/AAC.15.5.670
PMID:525984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC352736/
Abstract

The pharmacokinetics of the broad-spectrum penicillin Bay k 4999 were studied in six healthy male volunteers. A 2-g dose was given by the intravenous route. The tissue penetration of the antibiotic was studied by both dermabrasion and blister techniques. A total of 26.4% of the drug was recovered in the urine in 24 h, 79% of this being excreted in the first 2 h. The elimination half-life in serum was 1.3 h. The dermabrasion levels of Bay k 4999 were generally similar to those in serum, but after 1 h the blister fluid levels of antibiotic were greater than those in serum. Different drug levels obtained by blister and dermabrasion techniques may be due to the different composition of the two fluids.

摘要

在六名健康男性志愿者中研究了广谱青霉素Bay k 4999的药代动力学。通过静脉途径给予2克剂量。采用磨皮和水疱技术研究了该抗生素的组织穿透情况。24小时内尿液中总共回收了26.4%的药物,其中79%在最初2小时内排出。血清中的消除半衰期为1.3小时。Bay k 4999的磨皮水平通常与血清中的水平相似,但1小时后水疱液中的抗生素水平高于血清中的水平。通过水疱和磨皮技术获得的不同药物水平可能是由于这两种液体的成分不同。

相似文献

1
Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.新型广谱青霉素Bay k 4999的药代动力学
Antimicrob Agents Chemother. 1979 May;15(5):670-3. doi: 10.1128/AAC.15.5.670.
2
Clinical pharmacology of a new ureidopenicillin: Bay K 49999.
Chemotherapy. 1980;26(2):81-90. doi: 10.1159/000237887.
3
The pharmacokinetics of furazlocillin in healthy humans.呋苄西林在健康人体中的药代动力学。
J Pharmacokinet Biopharm. 1983 Feb;11(1):5-30. doi: 10.1007/BF01061765.
4
[Clinical pharmacokinetics of azlocillin].[阿洛西林的临床药代动力学]
Presse Med. 1984 Mar 29;13(13):788-96.
5
Pharmacokinetics of azlocillin in children with cystic fibrosis.
Arzneimittelforschung. 1979;29(12a):1955-7.
6
Pharmacokinetics and tissue penetration of temocillin.替莫西林的药代动力学及组织穿透性
Drugs. 1985;29 Suppl 5:106-8. doi: 10.2165/00003495-198500295-00022.
7
[Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].[阿洛西林——一种新型抗假单胞菌青霉素。文献综述与药代动力学研究]
Infection. 1982;10 Suppl 3:S184-90. doi: 10.1007/BF01640668.
8
Intravenous azlocillin kinetics in patients on long-term hemodialysis.长期血液透析患者静脉滴注阿洛西林的动力学
Clin Pharmacol Ther. 1980 Apr;27(4):563-6. doi: 10.1038/clpt.1980.80.
9
Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid.替卡西林/克拉维酸的药代动力学及组织穿透性:血清、尿液、淋巴液、吸疱液及皮下线液的同步研究
J Antimicrob Chemother. 1986 May;17 Suppl C:71-80. doi: 10.1093/jac/17.suppl_c.71.
10
Pharmacokinetics of azlocillin in healthy subjects.阿洛西林在健康受试者中的药代动力学。
Scand J Infect Dis Suppl. 1981;29:49-54.

引用本文的文献

1
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.广谱头孢菌素Ro 13-9904的药代动力学
Antimicrob Agents Chemother. 1980 Aug;18(2):240-2. doi: 10.1128/AAC.18.2.240.
2
Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.美洛西林、哌拉西林、Bay k 4999与羧苄西林和替卡西林对肠杆菌科细菌及铜绿假单胞菌的比较。
Infection. 1980;8(3):121-2. doi: 10.1007/BF01641477.

本文引用的文献

1
Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.羧苄青霉素:一种对绿脓杆菌有效的新型半合成青霉素。
Br Med J. 1967 Jul 8;3(5557):75-8. doi: 10.1136/bmj.3.5557.75.
2
A method for studying antibiotic concentrations in inflammatory exudate.一种研究炎性渗出物中抗生素浓度的方法。
J Clin Pathol. 1971 Oct;24(7):633-5. doi: 10.1136/jcp.24.7.633.
3
[Cefazolin, a new broad-spectrum antibiotic (author's transl)].头孢唑林,一种新型广谱抗生素(作者译)
Dtsch Med Wochenschr. 1973 Dec 21;98(51):2448-50. doi: 10.1055/s-0028-1107275.
4
Statistical estimations in pharmacokinetics.药物动力学中的统计学估计
J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504.
5
Pharmacokinetics of piperacillin following intravenous administration.
J Antimicrob Chemother. 1978 May;4(3):255-61. doi: 10.1093/jac/4.3.255.
6
[Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria].
Infection. 1977;5(3):170-82. doi: 10.1007/BF01639754.
7
[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].阿洛西林和美洛西林:两种新型半合成酰脲类青霉素(作者译)
Infection. 1977;5(3):163-9. doi: 10.1007/BF01639753.
8
In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity.哌拉西林的体外活性,一种具有异常广谱活性的新型半合成青霉素。
Antimicrob Agents Chemother. 1978 Mar;13(3):349-57. doi: 10.1128/AAC.13.3.349.
9
Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.新型抗假单胞菌广谱青霉素Bay k 4999和哌拉西林与其他β-内酰胺类药物的体外活性比较。
Antimicrob Agents Chemother. 1978 Oct;14(4):549-52. doi: 10.1128/AAC.14.4.549.
10
Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.阿洛西林和美洛西林对革兰氏阴性菌的活性:与其他青霉素类药物的比较。
Antimicrob Agents Chemother. 1978 Apr;13(4):559-65. doi: 10.1128/AAC.13.4.559.